Heidi Schilter

4.0k total citations · 2 hit papers
18 papers, 3.1k citations indexed

About

Heidi Schilter is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heidi Schilter has authored 18 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heidi Schilter's work include Microbial metabolism and enzyme function (10 papers), Dialysis and Renal Disease Management (3 papers) and Parasites and Host Interactions (3 papers). Heidi Schilter is often cited by papers focused on Microbial metabolism and enzyme function (10 papers), Dialysis and Renal Disease Management (3 papers) and Parasites and Host Interactions (3 papers). Heidi Schilter collaborates with scholars based in Australia, Brazil and United States. Heidi Schilter's co-authors include Mauro Martins Teixeira, Angélica T. Vieira, Charles R. Mackay, Ramnik J. Xavier, Di Yu, Aylwin Ng, Michael S. Rolph, Jan Kranich, Fabienne Mackay and David Artis and has published in prestigious journals such as Nature, Nature Communications and PLoS ONE.

In The Last Decade

Heidi Schilter

18 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

2009 2.5k citations Kendle M. Maslowski, Angélica T. Vieira et al. Nature profile →
Therapeutic targets in lung tissue remodelling and fibrosis

2021 163 citations Gang Liu, Ashleigh M. Philp et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi Schilter Australia	15	2.0k	839	485	392	360	18	3.1k
Alison N. Thorburn Australia	13	1.8k 0.9×	1.1k 1.3×	472 1.0×	303 0.8×	385 1.1×	17	3.1k
Sathish Sivaprakasam United States	19	2.5k 1.2×	836 1.0×	503 1.0×	375 1.0×	384 1.1×	38	3.6k
Caleb Kelly United States	23	2.4k 1.2×	900 1.1×	670 1.4×	484 1.2×	377 1.0×	41	4.1k
Bejan Saeedi United States	19	1.7k 0.9×	584 0.7×	526 1.1×	431 1.1×	268 0.7×	41	3.0k
Arnaud Muller Luxembourg	20	2.3k 1.1×	617 0.7×	340 0.7×	318 0.8×	389 1.1×	42	3.3k
Glauben Landskron Chile	10	2.6k 1.3×	733 0.9×	745 1.5×	417 1.1×	490 1.4×	17	4.5k
Marı́a Julieta González Chile	8	2.0k 1.0×	688 0.8×	385 0.8×	385 1.0×	465 1.3×	10	3.1k
Koshika Yadava Switzerland	15	2.0k 1.0×	1.1k 1.3×	681 1.4×	527 1.3×	334 0.9×	23	3.4k
Anke Sichelstiel Switzerland	8	1.7k 0.9×	917 1.1×	524 1.1×	471 1.2×	308 0.9×	9	2.8k
Craig I. McKenzie Australia	15	1.9k 0.9×	988 1.2×	479 1.0×	330 0.8×	423 1.2×	24	3.3k

Countries citing papers authored by Heidi Schilter

Since Specialization

Citations

This map shows the geographic impact of Heidi Schilter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Schilter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Schilter more than expected).

Fields of papers citing papers by Heidi Schilter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Schilter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Schilter. The network helps show where Heidi Schilter may publish in the future.

Co-authorship network of co-authors of Heidi Schilter

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Schilter. A scholar is included among the top collaborators of Heidi Schilter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Schilter. Heidi Schilter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Glaros, Elias N., Jonathan S. Foot, Heidi Schilter, et al.. (2025). Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease. Nature Communications. 16(1). 3430–3430. 1 indexed citations

Liu, Gang, Ashleigh M. Philp, Tamera J. Corte, et al.. (2021). Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacology & Therapeutics. 225. 107839–107839. 163 indexed citations breakdown →

Wong, May, Sonia Saad, Muh Geot Wong, et al.. (2020). Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy. PLoS ONE. 15(6). e0234617–e0234617. 6 indexed citations

Findlay, Alison D., Jonathan S. Foot, Alberto Buson, et al.. (2019). Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3. Journal of Medicinal Chemistry. 62(21). 9874–9889. 41 indexed citations

Stangenberg, Stefanie, Sonia Saad, Heidi Schilter, et al.. (2018). Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy. Scientific Reports. 8(1). 9423–9423. 27 indexed citations

Schilter, Heidi, Alison D. Findlay, Lara Perryman, et al.. (2018). The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis. Journal of Cellular and Molecular Medicine. 23(3). 1759–1770. 83 indexed citations

Schilter, Heidi, et al.. (2016). A novel SSAO inhibitor PXS-4728A suppresses inflammation and fibrosis and improves lung function in experimental chronic obstructive pulmonary disease.. 22 indexed citations

Jarnicki, Andrew, Heidi Schilter, Gang Liu, et al.. (2016). The inhibitor of semicarbazide‐sensitive amine oxidase, PXS‐4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model. British Journal of Pharmacology. 173(22). 3161–3175. 37 indexed citations

Schilter, Heidi, Adam Collison, Remo Castro Russo, et al.. (2015). Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration. Respiratory Research. 16(1). 42–42. 46 indexed citations

10.

Schilter, Heidi, Carmen Z. Cantemir-Stone, Vladimı́r Leksa, et al.. (2015). The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts. Immunology Letters. 165(2). 90–101. 15 indexed citations

11.

Wong, May, Sonia Saad, Jie Zhang, et al.. (2014). Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model. American Journal of Physiology-Renal Physiology. 307(8). F908–F916. 18 indexed citations

12.

Foot, Jonathan S., Tin T. Yow, Heidi Schilter, et al.. (2013). PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo. Journal of Pharmacology and Experimental Therapeutics. 347(2). 365–374. 45 indexed citations

13.

Starkey, Malcolm R., Richard Kim, Emma Beckett, et al.. (2012). Chlamydia muridarum Lung Infection in Infants Alters Hematopoietic Cells to Promote Allergic Airway Disease in Mice. PLoS ONE. 7(8). e42588–e42588. 30 indexed citations

14.

Tate, Michelle D., Heidi Schilter, Andrëw G. Brööks, & Patrick C. Reading. (2011). Responses of Mouse Airway Epithelial Cells and Alveolar Macrophages to Virulent and Avirulent Strains of Influenza A Virus. Viral Immunology. 24(2). 77–88. 64 indexed citations

15.

Schilter, Heidi, et al.. (2011). Protection against Nippostrongylus brasiliensis infection in mice is independent of GM‐CSF. Immunology and Cell Biology. 90(5). 553–558. 9 indexed citations

16.

Maslowski, Kendle M., Angélica T. Vieira, Aylwin Ng, et al.. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 461(7268). 1282–1286. 2484 indexed citations breakdown →

17.

Schilter, Heidi, et al.. (2009). Regulation of immune responses toStrongyloides venezuelensischallenge after primary infection with different larvae doses. Parasite Immunology. 32(3). 184–192. 19 indexed citations

18.

Schilter, Heidi, et al.. (2007). Evaluation of the immune response against Strongyloides venezuelensis in antigen‐immunized or previously infected mice. Parasite Immunology. 30(3). 139–149. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact